» Articles » PMID: 36002694

HMMR Promotes Peritoneal Implantation of Gastric Cancer by Increasing Cell-cell Interactions

Overview
Journal Discov Oncol
Publisher Springer
Specialty Oncology
Date 2022 Aug 24
PMID 36002694
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Distant metastasis is the prominent factor for cancer-induced death of gastric cancer in which peritoneum is one of the dominating targets of gastric cancer metastasis. However, there is still a lack of effective predictive indicators and treatment methods for gastric cancer patients with peritoneal metastasis.

Methods: A clustering assay was used to investigate the cell aggregates formation ability. While the soft agar assay and anoikis assay were performed to detect the anchorage-independent growth and anoikis-resistant ability respectively. Luciferase activity assay, western blotting and immunofluorescence were used to explore the effect of HMMR on AKT signaling activity. The peritoneal implantation model was examined to explore the role of HMMR in vivo.

Results: Silencing of HMMR expression markedly reduced the peritoneal metastasis of gastric cancer cells through reducing cell-cell interactions. Mechanistically, HA-HMMR could activate Akt signaling, thus succeeding in distant colonization and metastatic outgrowth. Importantly, inducible depletion of HMMR significantly abrogates peritoneal implantation of gastric cancer in vitro and in vivo.

Conclusion: Our study highlights that HMMR promotes peritoneal implantation of gastric cancer. A better understanding of HMMR's functions and mechanism might provide a novel therapeutic target and prognostic marker for metastatic gastric cancer.

Citing Articles

FOXM1 mediates methotrexate resistance in osteosarcoma cells by promoting autophagy.

Wang L, Zhai D, Tang L, Zhang H, Wang X, Ma N Acta Biochim Biophys Sin (Shanghai). 2024; 56(9):1289-1299.

PMID: 39086352 PMC: 11532242. DOI: 10.3724/abbs.2024084.


Transcriptome Analysis of Transiently Reversible Cell Vacuolization Caused by Excessive Serum Concentration in .

Song Y, Shao L, Yu X Biology (Basel). 2024; 13(7).

PMID: 39056737 PMC: 11274238. DOI: 10.3390/biology13070545.


Integrated bulk and single-cell RNA sequencing identifies an aneuploidy-based gene signature to predict sensitivity of lung adenocarcinoma to traditional chemotherapy drugs and patients' prognosis.

Wang X, Chen J, Li C, Liu Y, Chen S, Lv F PeerJ. 2024; 12:e17545.

PMID: 38938612 PMC: 11210463. DOI: 10.7717/peerj.17545.


Machine Learning Gene Signature to Metastatic ccRCC Based on ceRNA Network.

Farias E, Terrematte P, Stransky B Int J Mol Sci. 2024; 25(8).

PMID: 38673800 PMC: 11049832. DOI: 10.3390/ijms25084214.


Coupled scRNA-seq and Bulk-seq reveal the role of HMMR in hepatocellular carcinoma.

Su Z, He Y, You L, Zhang G, Chen J, Liu Z Front Immunol. 2024; 15:1363834.

PMID: 38633247 PMC: 11021596. DOI: 10.3389/fimmu.2024.1363834.


References
1.
Aceto N, Bardia A, Miyamoto D, Donaldson M, Wittner B, Spencer J . Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014; 158(5):1110-1122. PMC: 4149753. DOI: 10.1016/j.cell.2014.07.013. View

2.
Rossi E, Fassan M, Aieta M, Zilio F, Celadin R, Borin M . Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancer. Br J Cancer. 2012; 107(8):1286-94. PMC: 3494437. DOI: 10.1038/bjc.2012.388. View

3.
Hippo Y, Yashiro M, Ishii M, Taniguchi H, Tsutsumi S, Hirakawa K . Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res. 2001; 61(3):889-95. View

4.
Zhang H, Ren L, Ding Y, Li F, Chen X, Ouyang Y . Hyaluronan-mediated motility receptor confers resistance to chemotherapy TGFβ/Smad2-induced epithelial-mesenchymal transition in gastric cancer. FASEB J. 2019; 33(5):6365-6377. DOI: 10.1096/fj.201802186R. View

5.
Zhong J, Chen Y, Wang L . Emerging molecular basis of hematogenous metastasis in gastric cancer. World J Gastroenterol. 2016; 22(8):2434-40. PMC: 4768190. DOI: 10.3748/wjg.v22.i8.2434. View